Bill of Health

APRIL 24, 2023

Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. Glenn Cohen’s Health Law Policy, Bioethics, and Biotechnology Workshop at HLS.

Public Health 313

Public Health FDA Bioethics Governance 313

Bill of Health

JULY 27, 2023

face challenges in court, the legal, public health, medical, and bioethics communities have an essential role to play both in properly framing the legal issue, as well as explaining what is truly at stake in these cases to minimize the chances of similarly harmful rulings for the transgender community moving forward.

Bioethics 130

Bioethics Public Health Governance Doctors 130

Bill of Health

NOVEMBER 30, 2022

healthcare system, representing just one example of “healthcare federalism” — the division of power between the federal and state governments in the regulation of health care. Attorney General Merrick Garland made the position of the federal government clear, stating: “[T]he FDA has approved the use of the medication Mifepristone.

FDA 176

FDA Bioethics Public Health Governance 176